ASX Announcements 2010 Appendix 4E Preliminary Final Report 26/08/2010   Appendix 3B 10/08/2010   Resignation of Joint Company Secretary 21/07/2010   Appendix 4c Quarterly Cashflow Report 21/07/2010   Significant Progress on Licensing Opportunities 13/07/2010   ANP to present to Isis Shareholders in the US 19/05/2010   Appendix 3B 11/05/2010   Business Operations Update 04/05/2010   Appendix 4C - Quarterly Cashflow Report 29/04/2010   ATL1101 Prostatce Cancer Data presented at US Scientific Meeting 21/04/2010   ATL1102 License Agreement with Teva Pharmaceutical Industries Ltd 24/03/2010   Appendix 4D Half Yearly Report 17/02/2010   ATL1101 Data Presentation 10/02/2010   ATL1101 Prostate Tumour Suppression Data Published, Patent Granted 03/02/2010   Appendix 4C - Quarterly Cashflow Report 29/01/2010